Specify a stock or a cryptocurrency in the search bar to get a summary
Axim Biotechnologies Inc
AXIMAXIM Biotechnologies, Inc. engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California. Address: 6191 Cornerstone Court, East, San Diego, CA, United States, 92121
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures AXIM
Dividend Analytics AXIM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AXIM
Stock Valuation AXIM
Financials AXIM
Results | 2019 | Dynamics |